Cargando…

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Yu, Bo, Luo, Fei, Sun, Bowen, Liu, Wenxue, Shi, Qiqi, Cheng, Shi‐Yuan, Chen, Ceshi, Chen, Guoqiang, Li, Yanxin, Feng, Haizhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787397/ https://www.ncbi.nlm.nih.gov/pubmed/35075800 http://dx.doi.org/10.1002/advs.202105793

Ejemplares similares

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer
por: Yu, Bo, et al.
Publicado: (2021)

KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1
por: Liu, Wenxue, et al.
Publicado: (2021)

KAT8 selectively inhibits antiviral immunity by acetylating IRF3
por: Huai, Wanwan, et al.
Publicado: (2019)

The Kat in the HAT: The Histone Acetyl Transferase Kat6b (MYST4) Is Downregulated in Murine Macrophages in Response to LPS
por: Shukla, Smita, et al.
Publicado: (2018)

Correction: KAT8 selectively inhibits antiviral immunity by acetylating IRF3
por: Huai, Wanwan, et al.
Publicado: (2019)

ASEB: a web server for KAT-specific acetylation site prediction
por: Wang, Likun, et al.
Publicado: (2012)

KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification
por: Fournier, Marjorie, et al.
Publicado: (2016)

Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling
por: Hou, Yanli, et al.
Publicado: (2021)

KAT8 acetylation-controlled lipolysis affects the invasive and migratory potential of colorectal cancer cells
por: Qiu, Bingquan, et al.
Publicado: (2023)

The NLRP11 Protein Bridges the Histone Lysine Acetyltransferase KAT7 to Acetylate Vimentin in the Early Stage of Lung Adenocarcinoma
por: Yang, Rui, et al.
Publicado: (2023)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
por: Wang, Yufei, et al.
Publicado: (2020)

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
por: Hao, Zhaonian, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
por: Shi, Houhui, et al.
Publicado: (2021)

KAT5-mediated SOX4 acetylation orchestrates chromatin remodeling during myoblast differentiation
por: Jang, S-M, et al.
Publicado: (2015)

KAT2-mediated PLK4 acetylation contributes to genomic stability by preserving centrosome number
por: Fournier, Marjorie, et al.
Publicado: (2016)

Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A
por: Pacifico, Roberta, et al.
Publicado: (2022)

KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements
por: Au, Yan Zi, et al.
Publicado: (2021)

HOXC10 Promotes Metastasis in Colorectal Cancer by Recruiting Myeloid-derived Suppressor Cells
por: Yu, Jiao, et al.
Publicado: (2022)

Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
por: Hao, Zhaonian, et al.
Publicado: (2022)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
por: Wu, Yuze, et al.
Publicado: (2022)

PB1803: SMAD1 IS A TUMOR SUPPRESSOR IN ACUTE MYELOID LEUKEMIA WITH MLL REARRANGEMENT
por: Dietsche, Lisa, et al.
Publicado: (2023)

KAT2-mediated acetylation switches the mode of PALB2 chromatin association to safeguard genome integrity
por: Fournier, Marjorie, et al.
Publicado: (2022)

MG149 inhibits histone acetyltransferase KAT8-mediated IL-33 acetylation to alleviate allergic airway inflammation and airway hyperresponsiveness
por: Liu, Yahui, et al.
Publicado: (2021)

BATF2 prevents glioblastoma multiforme progression by inhibiting recruitment of myeloid-derived suppressor cells
por: Zhang, Xin, et al.
Publicado: (2021)

Myeloid-derived suppressor cells—new and exciting players in lung cancer
por: Yang, Zhenzhen, et al.
Publicado: (2020)

Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
por: Lesokhin, Alexander M., et al.
Publicado: (2013)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer
por: Ding, Yixin, et al.
Publicado: (2015)

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing
por: Viita, Tiina, et al.
Publicado: (2019)

KAT3-dependent acetylation of cell type-specific genes maintains neuronal identity in the adult mouse brain
por: Lipinski, Michal, et al.
Publicado: (2020)

Acetylation of Checkpoint suppressor 1 enhances its stability and promotes the progression of triple-negative breast cancer
por: Xu, Zhaowei, et al.
Publicado: (2022)

METTL3-mediated m6A methylation regulates ovarian cancer progression by recruiting myeloid-derived suppressor cells
por: Wang, Jinyong, et al.
Publicado: (2023)

CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification
por: Jie, Mengmeng, et al.
Publicado: (2020)

Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
por: Jin, Shuiling, et al.
Publicado: (2020)

Pseudomonas aeruginosa Airway Infection Recruits and Modulates Neutrophilic Myeloid-Derived Suppressor Cells
por: Öz, Hasan H., et al.
Publicado: (2016)

Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
por: Lim, Hui Xuan, et al.
Publicado: (2020)

Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7
por: Zhang, Zhengkui, et al.
Publicado: (2017)

Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
por: Draghiciu, Oana, et al.
Publicado: (2015)

Role of myeloid-derived suppressor cells in the promotion and immunotherapy of colitis-associated cancer
por: Wang, Yungang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5t8g95cfa7cn264is8l89pljse